AI Reads Brain Hemorrhage Images Within Seconds

SK C&C's 'Brain Hemorrhage Imaging AI Model' Obtains GMP Compliance Certification

[Asia Economy Reporter Jin-gyu Lee] SK Inc. C&C announced on the 18th that its 'Intracerebral Hemorrhage Imaging AI Model,' which determines intracerebral hemorrhage within seconds, has obtained certification for compliance with Good Manufacturing Practice (GMP) for medical device manufacturing and quality control standards.

SK C&C developed the intracerebral hemorrhage imaging AI model using CT images from Seoul National University Hospital as the second phase, following the first phase at Ajou University Medical Center. The model training utilized SK C&C Vision AI's image segmentation technology along with approximately 80,000 brain CT images and interpretation data.

The intracerebral hemorrhage imaging AI model provides interpretation information at the level of a radiology specialist within seconds. Since intracerebral hemorrhage is an emergency disease that must be treated within the golden time, fast and accurate image interpretation is a critical area.

SK C&C expects this to help early diagnosis and treatment of emergency intracerebral hemorrhage patients where every second counts. Yoon Dong-jun, head of SK C&C Healthcare Group, said, "The AI-based imaging interpretation model can be expanded not only to intracerebral hemorrhage but also to brain infarction, brain tumors, and other neurological diseases," adding, "We will contribute to the development of domestic medical AI services focusing on brain diseases by collaborating with medical institutions at home and abroad."

GMP is a quality assurance system that guarantees whether medical devices produced by medical device manufacturers can be consistently produced with quality suitable for their intended use by verifying the safety and efficacy of the medical devices. After obtaining this GMP certification, SK C&C has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Safety for review. Clinical trials are scheduled to be conducted at multiple institutions within this year.

This content was produced with the assistance of AI translation services.